- call +1-201-465-4211
- email sales@mrinsights.biz
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Scope of the Report:
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
The worldwide market for Hepatitis A Vaccine is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 770 million US$ in 2024, from 650 million US$ in 2019, according to a new study.
This report focuses on the Hepatitis A Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inactivated Vaccine
Live Attenuated Vaccine
Market Segment by Applications, can be divided into
Government Institution
Private Sector
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales, revenue and global market share of Hepatitis A Vaccine in 2017 and 2018.
Chapter 3, the Hepatitis A Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hepatitis A Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Inactivated Vaccine
1.2.2 Live Attenuated Vaccine
1.3 Market Analysis by Applications
1.3.1 Government Institution
1.3.2 Private Sector
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Hepatitis A Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Hepatitis A Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Hepatitis A Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sinovac
2.4.1 Business Overview
2.4.2 Hepatitis A Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Zhejiang Pukang
2.5.1 Business Overview
2.5.2 Hepatitis A Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Changchun Institute of Biological
2.6.1 Business Overview
2.6.2 Hepatitis A Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Kaketsuken
2.7.1 Business Overview
2.7.2 Hepatitis A Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 IMBCA
2.8.1 Business Overview
2.8.2 Hepatitis A Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 ChangSheng
2.9.1 Business Overview
2.9.2 Hepatitis A Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Convac
2.10.1 Business Overview
2.10.2 Hepatitis A Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hepatitis A Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Hepatitis A Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Hepatitis A Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Hepatitis A Vaccine Market Analysis by Regions
4.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Hepatitis A Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
5 North America Hepatitis A Vaccine by Country
5.1 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Hepatitis A Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Hepatitis A Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
6 Europe Hepatitis A Vaccine by Country
6.1 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Hepatitis A Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Hepatitis A Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
6.4 France Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Hepatitis A Vaccine by Country
7.1 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Hepatitis A Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Hepatitis A Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
7.5 India Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
8 South America Hepatitis A Vaccine by Country
8.1 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Hepatitis A Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Hepatitis A Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Hepatitis A Vaccine by Countries
9.1 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Hepatitis A Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Hepatitis A Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Hepatitis A Vaccine Sales and Growth Rate (2014-2019)
10 Global Hepatitis A Vaccine Market Segment by Type
10.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Hepatitis A Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Inactivated Vaccine Sales Growth and Price
10.2.1 Global Inactivated Vaccine Sales Growth (2014-2019)
10.2.2 Global Inactivated Vaccine Price (2014-2019)
10.3 Live Attenuated Vaccine Sales Growth and Price
10.3.1 Global Live Attenuated Vaccine Sales Growth (2014-2019)
10.3.2 Global Live Attenuated Vaccine Price (2014-2019)
11 Global Hepatitis A Vaccine Market Segment by Application
11.1 Global Hepatitis A Vaccine Sales Market Share by Application (2014-2019)
11.2 Government Institution Sales Growth (2014-2019)
11.3 Private Sector Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Hepatitis A Vaccine Market Forecast (2019-2024)
12.1 Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Hepatitis A Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Hepatitis A Vaccine Market Forecast (2019-2024)
12.2.2 Europe Hepatitis A Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Hepatitis A Vaccine Market Forecast (2019-2024)
12.2.4 South America Hepatitis A Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Hepatitis A Vaccine Market Forecast (2019-2024)
12.3 Hepatitis A Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Hepatitis A Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Hepatitis A Vaccine Market Share Forecast by Type (2019-2024)
12.4 Hepatitis A Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Hepatitis A Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Hepatitis A Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hepatitis A Vaccine Picture
Table Product Specifications of Hepatitis A Vaccine
Figure Global Sales Market Share of Hepatitis A Vaccine by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
